Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

LeMaitre Vascular, Inc. (LMAT)

44.64   -1.52 (-3.29%) 11-28 16:00
Open: 45.96 Pre. Close: 46.16
High: 46.32 Low: 44.53
Volume: 65,542 Market Cap: 982(M)

Technical analysis

as of: 2022-11-28 4:41:17 PM
Stoxline posted a STRONG SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 56.99     One year: 62.06
Support: Support1: 41.77    Support2: 34.76
Resistance: Resistance1: 48.8    Resistance2: 53.13
Pivot: 45.35
Moving Average: MA(5): 45.72     MA(20): 45
MA(100): 48.99     MA(250): 46.82
MACD: MACD(12,26): -0.6     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 59.8     %D(3): 67.3
RSI: RSI(14): 42.1
52-week: High: 56.38  Low: 38.31
Average Vol(K): 3-Month: 94 (K)  10-Days: 56 (K)

Price, moving averages and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ LMAT ] has closed above bottom band by 28.7%. Bollinger Bands are 47.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 46.34 - 46.65 46.65 - 46.91
Low: 43.94 - 44.24 44.24 - 44.49
Close: 44.2 - 44.69 44.69 - 45.09

Company Description

LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid shunts that temporarily shunt the blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and radiopaque tape, a medical-grade tape applied to the skin that enables interventionists to cross-refer between the inside and the outside of a patient's body, and allows them to locate tributaries or lesions beneath the skin. In addition, it offers valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and vascular grafts to bypass or replace diseased arteries. Further, the company provides vascular and cardiac patches, which are used for closure of vessels after surgical intervention; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

Headline News

Wed, 23 Nov 2022
Is This Underfollowed Dividend Stock a Buy? - The Motley Fool

Tue, 22 Nov 2022
LeMaitre to Present at Upcoming Investor Conferences - LeMaitre Vascular (NASDAQ:LMAT) - Benzinga

Tue, 15 Nov 2022
LMAT Makes Bullish Cross Above Critical Moving Average - Nasdaq

Fri, 11 Nov 2022
Why You Might Be Interested In LeMaitre Vascular, Inc. (NASDAQ:LMAT) For Its Upcoming Dividend - Simply Wall St

Sat, 29 Oct 2022
LeMaitre Vascular, Inc. Plans Quarterly Dividend of $0.13 (NASDAQ:LMAT) - MarketBeat

Fri, 28 Oct 2022
LeMaitre stock slumps 16% amid Q3 miss, slashed outlook (NASDAQ:LMAT) - Seeking Alpha

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Medical Instruments & Supplies
Shares Out. 22 (M)
Shares Float 19 (M)
% Held by Insiders 11.9 (%)
% Held by Institutions 88.8 (%)
Shares Short 806 (K)
Shares Short P.Month 912 (K)

Stock Financials

EPS 0.94
EPS Est Next Qtl 0.2
EPS Est This Year 0.8
EPS Est Next Year 0.87
Book Value (p.s.) 11.86
Profit Margin (%) 13.2
Operating Margin (%) 19.5
Return on Assets (ttm) 6.6
Return on Equity (ttm) 8.3
Qtrly Rev. Growth 1.7
Gross Profit (p.s.) 4.6
Sales Per Share 7.28
EBITDA (p.s.) 1.87
Qtrly Earnings Growth -17.3
Operating Cash Flow 26 (M)
Levered Free Cash Flow 26 (M)

Stock Valuations

PE Ratio 46.98
PEG Ratio 18
Price to Book value 3.76
Price to Sales 6.13
Price to Cash Flow 37.25

Stock Dividends

Dividend 0.11
Forward Dividend 0
Dividend Yield 0.2%
Dividend Pay Date 2021-12-01
Ex-Dividend Date 2021-11-17
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.